Identification of Additional Anti-Persister Activity against Borrelia burgdorferi from an FDA Drug Library
Lyme disease is a leading vector-borne disease in the United States. Although the majority of Lyme patients can be cured with standard 2–4 week antibiotic treatment, 10%–20% of patients continue to suffer from prolonged post-treatment Lyme disease syndrome (PTLDS). While the cause for this is uncle...
Main Authors: | Jie Feng, Megan Weitner, Wanliang Shi, Shuo Zhang, David Sullivan, Ying Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-09-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | http://www.mdpi.com/2079-6382/4/3/397 |
Similar Items
-
Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library
by: Jie Feng, et al.
Published: (2014-01-01) -
A Drug Combination Screen Identifies Drugs Active against Amoxicillin-induced Round Bodies of Borrelia burgdorferi Persisters from an FDA Drug Library
by: Jie eFeng, et al.
Published: (2016-05-01) -
Eradication of Biofilm-like Microcolony Structures of Borrelia burgdorferi by Daunomycin and Daptomycin but not Mitomycin C in Combination with Doxycycline and Cefuroxime
by: Jie eFeng, et al.
Published: (2016-02-01) -
Identification of Essential Oils with Strong Activity against Stationary Phase Borrelia burgdorferi
by: Jie Feng, et al.
Published: (2018-10-01) -
Ceftriaxone Pulse Dosing Fails to Eradicate Biofilm-like Microcolony B. burgdorferi Persisters Which Are Sterilized by Daptomycin/Doxycycline/Cefuroxime Drug Combination without Pulse Dosing
by: Jie Feng, et al.
Published: (2016-11-01)